Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia : a retrospective I-BFM analysis of 333 children

Autor: Arjan C. Lankester, Alice Bertaina, Andrew S. Moore, Birgitta Versluys, Jacek Wachowiak, Theodor Uden, Ian Nivison-Smith, Marc Ansari, Franco Locatelli, Kirsten Mischke, Martin Zimmermann, Henrik Hasle, Corinne Gerhardt, Jerry Stein, Leen Willems, Marc Bierings, Christina Peters, Martin Sauer, Jonas Abrahamsson, Dirk Reinhardt, Petr Sedlacek, Anna Pieczonka, Jean-Pierre Bourquin, Adriana Balduzzi

Publikováno v: British journal of haematology, Vol. 189, No 4 (2020) pp. 745-750
Uden, T, Bertaina, A, Abrahamsson, J, Ansari, M, Balduzzi, A, Bourquin, J-P, Gerhardt, C, Bierings, M, Hasle, H, Lankester, A, Mischke, K, Moore, A S, Nivison-Smith, I, Pieczonka, A, Peters, C, Sedlacek, P, Reinhardt, D, Stein, J, Versluys, B, Wachowiak, J, Willems, L, Zimmermann, M, Locatelli, F & Sauer, M G 2020, ' Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia : a retrospective I-BFM analysis of 333 children ', British Journal of Haematology, vol. 189, no. 4, pp. 745-750 . https://doi.org/10.1111/bjh.16441
British Journal of Haematology. WILEY
British Journal of Haematology

Outcome of 333 children with acute myeloid leukaemia relapsing after a first allogeneic haematopoietic stem cell transplantation was analyzed. Four-year probability of overall survival (4y-pOS) was 14%. 4y-pOS for 122 children receiving a second haem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::857d4011eee946472e5bff2043cee0f4
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85078877303

Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial

Autor: Petr Sedlacek, Christine Pohler, Brigitte Strahm, Peter Lang, Christina Peters, Martin Zimmermann, Wolfgang Holter, Roland Meisel, Matthias Eyrich, Peter Bader, Martin Sauer, Wilhelm Woessmann, Bernd Gruhn, Ursula Creutzig, C Mauz-Körholz, Johanna Schrum, Arndt Borkhardt, Charlotte M. Niemeyer, Johann Greil, Birgit Burkhardt, Michael H. Albert, Bernhard Kremens, Ansgar Schulz, Rupert Handgretinger, Paul G. Schlegel, Dirk Reinhardt, Thomas Klingebiel, Heiko von der Leyen, Ingo Müller, Kirsten Mischke

Publikováno v: Leukemia. 34(5)

AML SCT-BFM 2007 was the first hematopoietic stem cell transplantation (HCT) trial in Germany to comply with the European Clinical Trials Directive, and aimed to standardize pediatric HCT for acute myeloid leukemia (AML) across centers in Germany, Au

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::733e318adc2c44e2ac55b6ef00fbdb3b
https://pubmed.ncbi.nlm.nih.gov/31578451